跳至主要内容
临床试验/NCT02954094
NCT02954094进行中(未招募)不适用

A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma

Target PharmaSolutions, Inc.71 个研究点 分布在 5 个国家目标入组 10,000 人开始时间: 2016年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
10,000
试验地点
71
主要终点
Establish a longitudinal observational cohort to understand the natural history and management of HCC, including the safety and outcomes of HCC treatment interventions utilized in usual clinical practice

研究概览

简要总结

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients, age ≥18 years
  • Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

排除标准

  • 1. Inability to provide written informed consent

结局指标

主要结局

Establish a longitudinal observational cohort to understand the natural history and management of HCC, including the safety and outcomes of HCC treatment interventions utilized in usual clinical practice

时间窗: Up to 15 years

次要结局

  • Evaluate the impact of HCC treatment interventions and concomitant medications on comorbid conditions and liver function(Up to 15 years)
  • Evaluate patient-reported outcomes measures during the natural course of HCC and management with HRQoL questionnaires(Up to 15 years)
  • Establish a Biorepository Specimen Bank (BSB)(Up to 15 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (71)

Loading locations...

相似试验